DELAFIELD, Wis. (Stockpickr) -- As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Halcon Resources

HK Price ChartHK Price data by YCharts

Halcon Resources  (HK - Get Report), an independent energy company, is engaged in the acquisition, production, exploration and development of onshore oil and natural gas properties in the U.S. This stock is trading up 1.77% to $1.15 in Tuesday's trading session.

  • Tuesday's Range: $1.06-$1.19
  • 52-Week Range: $1.01-$7.00
  • Tuesday's Volume: 3.25 million
  • Three-Month Average Volume: 6.21 million

From a technical perspective, Halcon Resources is spiking modestly higher here right above its 52-week low of $1.01 with decent upside volume flows. This spike to the upside on Tuesday is starting to push shares of Halcon Resources within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some key near-term overhead resistance levels at its 50-day moving average of $1.20 and then above some more key resistance at around $1.25 with high volume.

Traders should now look for long-biased trades in Halcon Resources as long as it's trending above Tuesday's intraday low of $1.06 and then once it sustains a move or close above those breakout levels with volume that hits near or above 6.21 million shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.30 to $1.38, or even $1.40 to $1.50 a share.

AcelRx Pharmaceuticals

ACRX Price ChartACRX Price data by YCharts

AcelRx Pharmaceuticals  (ACRX - Get Report), a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. This stock is trading up 5.5% to $4.35 in Tuesday's trading session.

  • Tuesday's Range: $4.10-$4.35
  • 52-Week Range: $2.96-$11.38
  • Tuesdays Volume: 93,000
  • Three-Month Average Volume: 639,006

From a technical perspective, AcelRx Pharmaceuticals is ripping higher here right above some near-term support at around $4 with lighter-than-average volume. This spike to the upside on Tuesday is starting to push shares of AcelRx Pharmaceuticals within range of triggering a near-term breakout trade and potentially a major breakout trade. That trade will trigger if this stock manages to take out some key near-term overhead resistance levels at $4.46 and then once it clears some major resistance levels at $4.90 to $4.99 with high volume.

Traders should now look for long-biased trades in AcelRx Pharmaceuticals as long as it's trending above some key near-term support at $4 and then once it sustains a move or close above those breakout levels with volume that hits near or above 639,006 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $5.57 to right around $6 a share.

Oramed Pharmaceuticals

ORMP Price ChartORMP Price data by YCharts

Oramed Pharmaceuticals  (ORMP - Get Report) engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. This stock is trading up 2.8% to $7.45 in Tuesday's trading session.

Tuesday's Range: $7.25-$7.48
52-Week Range: $3.71-$10.20
Tuesday's Volume: 42,000
Three-Month Average Volume: 155,702

From a technical perspective, Oramed Pharmaceuticals is trending notably to the upside here right above some near-term support at $7 with lighter-than-average volume. This stock has been uptrending strong over the last month, with shares moving higher from its low of $5.22 to its recent high of $7.65. During that uptrend, shares of Oramed Pharmaceuticals have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed this stock within range of triggering a major breakout trade above some key overhead resistance levels. That breakout will hit if this stock manages to take out some key overhead resistance levels at $7.65 to $7.91 with high volume.

Traders should now look for long-biased trades in Oramed Pharmaceuticals as long as it's trending above some near-term support at $7 or above its 50-day at $6.69 and then once it sustains a move or close above those breakout levels with volume that hits near or above 155,702 shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.50 to $9, or even $9.50 to $9.84 a share.

This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.